Neuroimaging biomarkers to predict treatment response in schizophrenia: The end of 30 years of solitude?

Dialogues in Clinical Neuroscience

Volumn 16, Issue 4, 2014, Pages 491-503

  Dazzan, Paola ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

First episode schizophrenia; Magnetic resonance imaging; Psychosis

Indexed keywords

BIOLOGICAL MARKER; NEUROLEPTIC AGENT;

ACCURACY; ARTICLE; HUMAN; MACHINE LEARNING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PSYCHOSIS; SCHIZOPHRENIA; SOCIAL ISOLATION; SUPPORT VECTOR MACHINE; TREATMENT RESPONSE; ARTIFICIAL INTELLIGENCE; COMPUTER ASSISTED DIAGNOSIS; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

ANTIPSYCHOTIC AGENTS; ARTIFICIAL INTELLIGENCE; BIOMARKERS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA; SUPPORT VECTOR MACHINE;

EID: 84925296862     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361:281-288.
2. Dazzan P, Soulsby B, Mechelli A, et al. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull. 2012;38:1083-1091.
3. Carletti F, Woolley JB, Bhattacharyya S, et al. Alterations in white matter evident before the onset of psychosis. Schizophr Bull. 2012;38:1170- 1179.
4. Ellison-Wright I, Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res. 2009;108:3-10.
5. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry. 2008;165:1015-1023.
6. Fusar-Poli P, Radua J, McGuire P, Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr Bull. 2012;38:1297-1307.
7. Kasparek T, Prikryl R, Schwarz D, et al. Gray matter morphology and the level of functioning in one-year follow-up of first-episode schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1438-1446.
8. Jääskeläinen E, Juola P, Kurtti J, et al. Associations between brain morphology and outcome in schizophrenia in a general population sample. Eur Psychiatry. 2014;29:456-462.
9. Wassink TH, Andreasen NC, Nopoulos P, Flaum M. Cerebellar morphology as a predictor of symptom and psychosocial outcome in schizophrenia. Biol Psychiatry. 1999;45:41-48.
10. van Haren NE, Cahn W, Hulshoff Pol HE, et al. Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study. Schizophr Res. 2003;64:41-52.
11. Mitelman SA, Newmark RE, Torosjan Y, et al. White matter fractional anisotropy and outcome in schizophrenia. Schizophr Res. 2006;87:138-159.
12. Mane A, Falcon C, Mateos JJ, et al. Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM. Schizophr Res. 2009;114:136-143.
13. van Haren NE, Hulshoff Pol HE, Schnack HG, et al. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year followup study. Neuropsychopharmacology. 2007;32:2057-2066.
14. van Haren NE, Schnack HG, Cahn W, et al. Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry. 2011;68:871-880.
15. Arango C, Rapado-Castro M, Reig S, et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry. 2012;69:16-26.
16. Lappin JM, Morgan C, Chalavi S, et al. Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes. Psychol Med. 2013:1-13.
17. Navari S, Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med. 2009;39:1763-1777.
18. Boter H, Peuskens J, Libiger J, et al; EUFEST study group. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). Schizophr Res. 2009;115:97-103.
19. Emsley R, Rabinowitz J, Medori R. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophr Res. 2007;89:129-139.
20. Lambert M, Naber D, Schacht A, et al. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatr Scand. 2008;118:220-229.
21. Friedman L, Lys C, Schulz SC. The relationship of structural brain imaging parameters to antipsychotic treatment response: a review. J Psychiatry Neurosci. 1992;17:42-54.
22. Zipursky RB, Zhang-Wong J, Lambe EK, Bean G, Beiser M. MRI correlates of treatment response in first episode psychosis. Schizophr Res. 1998;30:81-90.
23. Honer WG, Smith GN, Lapointe JS, MacEwan GW, Kopala L, Altman S. Regional cortical anatomy and clozapine response in refractory schizophrenia. Neuropsychopharmacology. 1995;13:85-87.
24. Konicki PE, Kwon KY, Steele V, et al. Prefrontal cortical sulcal widening associated with poor treatment response to clozapine. Schizophr Res. 2001;48:173-176.
25. Friedman L, Knutson L, Shurell M, Meltzer HY. Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia. Biol Psychiatry. 1991;29:865-877.
26. Arango C, Breier A, McMahon R, Carpenter WT Jr, Buchanan RW. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes. Am J Psychiatry. 2003;160:1421-1427.
27. Molina V, Reig S, Sarramea F, et al. Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia. Psychiatry Res. 2003;124:153-161.
28. Bodnar M, Harvey PO, Malla AK, Joober R, Lepage M. The parahippocampal gyrus as a neural marker of early remission in first-episode psychosis: a voxel-based morphometry study. Clinical Schizophr Rel Psychoses. 2011;4:217-228.
29. Molina V, Martin C, Ballesteros A, de Herrera AG, Hernandez-Tamames JA. Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics. Eur Arch Psychiatry Clin Neurosci. 2011;261:407-416.
30. Garver DL, Holcomb JA, Christensen JD. Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int J Neuropsychopharmacology. 2008;11:49-61.
31. Luck D, Buchy L, Czechowska Y, et al. Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study. J Psychiatr Res. 2011;45:369-377.
32. Palaniyappan L, Marques TR, Taylor H, et al. Cortical folding defects as markers of poor treatment response in first-episode psychosis. JAMA Psychiatry. 2013;70:1031-1040.
33. Reis Marques TR, Taylor H, Chaddock CA, et al. White matter integrity as predictor of response to treatment in first episode psychosis. Brain. 2014;137:172-182.
34. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441-449.
35. Mangin JF, Jouvent E, Cachia A. In-vivo measurement of cortical morphology: means and meanings. Curr Opin Neurol. 2010;23:359-367.
36. Palaniyappan L, Liddle PF. Aberrant cortical gyrification in schizophrenia: a surface-based morphometry study. J Psychiatry Neurosci. 2012;37:399-406.
37. Gimenez M, Junque C, Vendrell P, et al. Abnormal orbitofrontal development due to prematurity. Neurology. 2006;67:1818-1822.
38. Haukvik UK, Schaer M, Nesvag R, et al. Cortical folding in Broca's area relates to obstetric complications in schizophrenia patients and healthy controls. Psychol Med. 2012;42:1329-37.
39. Palaniyappan L, Liddle PF. Dissociable morphometric differences of the inferior parietal lobule in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2012;262:579-587.
40. Koutsouleris N, Meisenzahl EM, Davatzikos C, et al. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry. 2009;66:700- 712.
41. Sun D, van Erp TG, Thompson PM, et al. Elucidating a magnetic resonance imaging-based neuroanatomic biomarker for psychosis: classification analysis using probabilistic brain atlas and machine learning algorithms. Biol Psychiatry. 2009;66:1055-1060.
42. Pettersson-Yeo W, Benetti S, Marquand AF, et al. Using genetic, cognitive and multi-modal neuroimaging data to identify ultra-high-risk and first-episode psychosis at the individual level. Psychol Med. 2013;43:2547- 2562.
43. Mourao-Miranda J, Reinders AA, Rocha-Rego V, et al. Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study. Psychol Med. 2012;42:1037-1047.
44. Koutsouleris N, Riecher-Rossler A, Meisenzahl EM, et al. Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers. Schizophr Bull. 2014 Jun 9. [Epub ahead of print].
45. Tognin S, Pettersson-Yeo W, Valli I, et al. Using structural neuroimaging to make quantitative predictions of symptom progression in individuals at ultra-high risk for psychosis. Front Psychiatry. 2013;4:187.
46. Malla A, Norman R, Bechard-Evans L, Schmitz N, Manchanda R, Cassidy C. Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service. Psychol Med. 2008;38:1585-1593.
47. Eack SM, Greenwald DP, Hogarty SS, Keshavan MS. One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia. Schizophr Res. 2010;120:210-216.